Home / Healthcare / Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020

Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020

Published: Jun 2015 | No Of Pages: 125 | Published By: P & S Market Research

Human insulin in the report refers to synthetic insulin manufactured in laboratories by growing insulin protein with the help of E. coli bacteria.

Key findings of Human Insulin Market:

The key findings of the report “Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020” include:

Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market
Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the growth of the human insulin market
Geographically, North America has the largest share in global human insulin market, while Asia-Pacific has emerged as the fastest growing region
Based on the type, modern human insulin has the largest market share in the human insulin market
Increasing usage of insulin pens for the administration of insulin helps to inject insulin accurately. In addition, growing demand of biosimilar drugs due to its cost effectiveness is an opportunity for the growth of the market.

Human insulin market is growing moderately due to increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity. However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market.

Globally, modern human insulin has the largest market share and is also the fastest growing human insulin type. In addition, long acting human insulin has the largest market share in the modern human insulin market, and premixed human insulin is the fastest growing modern human insulin in the market. Long acting human insulin is prescribed by physicians for the treatment of type 2 diabetes. It is absorbed slowly and works for long time to control the sugar level between meal and sleep.

The key competitors in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar. 

Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable)
  • Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments and merger acquisitions
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics.
  • Profiles provide better understanding of competition as well as the demands of the market.

Scope of Report

The research offers Human Insulin market size and market forecast for the period 2011 to 2020. The market size is breakdown as follows:

GLOBAL MARKET BREAKDOWN

  • By type – includes global market size of traditional human insulin and modern human insulin
  • By brand – includes global market size of Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin and Insuman
  • By region – includes market size of North America, Europe, Asia-Pacific and Rest of World

GLOBAL MARKET BREAKDOWN BY TYPE

  • Traditional human insulin market breakdown by region – North America, Europe, Asia-Pacific and Rest of World
  • Modern human insulin breakdown by region – North America, Europe, Asia-Pacific and Rest of World

GLOBAL MARKET BREAKDOWN BY TYPE OF TRADITIONAL HUMAN INSULIN

  • Short acting human insulin market breakdown by region – North America, Europe, Asia-Pacific and Rest of World
  • Intermediate acting human insulin market breakdown by region – North America, Europe, Asia-Pacific and Rest of World
  • Premixed human insulin market breakdown by region – North America, Europe, Asia-Pacific and Rest of World

GLOBAL MARKET BREAKDOWN BY TYPE OF MODERN HUMAN INSULIN

  • Long acting human insulin market breakdown by region – North America, Europe, Asia-Pacific and Rest of World
  • Rapid acting human insulin market breakdown by region – North America, Europe, Asia-Pacific and Rest of World
  • Premixed human insulin market breakdown by region – North America, Europe, Asia-Pacific and Rest of World

GLOBAL MARKET BREAKDOWN BY GEOGRAPHY
North America Market Breakdown

  • North America market breakdown by type:
    • Traditional human insulin by type – short acting human insulin, intermediate acting human insulin and premixed human insulin
    • Modern human insulin by type – long action human insulin, rapid acting human insulin and premixed human insulin
  • North America market breakdown by country – the U.S., Canada and Rest of North America
    • The U.S. market breakdown by type –
      • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
      • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin
    • Canada market breakdown by type –
      • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
      • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin

Europe Market Breakdown

  • Europe market breakdown by type:
    • Traditional human insulin by type – short acting human insulin, intermediate acting human insulin and premixed human insulin
    • Modern human insulin by type – long action human insulin, rapid acting human insulin and premixed human insulin
  • Europe market breakdown by country – Germany, France, the U.K. and Rest of Europe
    • Germany market breakdown by type –
      • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
      • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin
    • France market breakdown by type –
      • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
      • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin
    • The U.K. market breakdown by type –
      • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
      • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin

Asia-Pacific Market Breakdown

  • Asia-Pacific market breakdown by type:
    • Traditional human insulin by type – short acting human insulin, intermediate acting human insulin and premixed human insulin
    • Modern human insulin by type – long action human insulin, rapid acting human insulin and premixed human insulin
  • Asia-Pacific market breakdown by country – Japan, India, China and Rest of Asia-Pacific
    • Japan market breakdown by type –
      • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
      • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin
    • India market breakdown by type –
      • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
      • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin
    • China market breakdown by type –
    • Traditional human insulin – short acting human insulin, intermediate acting human insulin and premixed human insulin
    • Modern human insulin – long action human insulin, rapid acting human insulin and premixed human insulin

Rest Of World Market Breakdown

  • Rest of World market breakdown by type:
    • Traditional human insulin by type – short acting human insulin, intermediate acting human insulin and premixed human insulin
    • Modern human insulin by type – long action human insulin, rapid acting human insulin and premixed human insulin

Chapter 1            Research Scope and Methodology

1.1          Market Definition

1.2          Market Scope

   1.2.1          Market Breakdown by Type

   1.2.2          Market Breakdown by Brand

   1.2.3          Market Breakdown by Geography

1.3         Research Methodology and Sources

Chapter 2            Executive Summary

2.1          Key Findings

2.2          Research Summary

Chapter 3            Market Outlook              

3.1          Introduction

3.2          Trends in the Market

   3.2.1      Rising usage of insulin pen for the administration of human insulin

3.3          Opportunities in the Market

   3.3.1      Growing demand of biosimilar drugs due to its cost effectiveness

3.4          Factors Driving the Market and its Impact on Market Forecast

   3.4.1      Rising aging population

   3.4.2      Increasing diabetic population

   3.4.3      Rising prevalence of obesity

   3.4.4      Technological advancement in drug delivery devices

   3.4.5      Increasing awareness about diabetic care

   3.4.6      Impact analysis of drivers on market forecast

3.5          Factors Hindering the Market and its Impact on Market Forecast

   3.5.1      High insulin analogue cost

   3.5.2      Strict regulatory requirements for approval of human insulin

   3.5.3      Impact analysis of restraints on market forecast

Chapter 4            Global Market Size and Forecasts (2011 – 2020)

4.1          Global Market Breakdown by Type

4.2          Global Tradition Human Insulin Market Breakdown by Type

4.3          Global Modern Human Insulin Market Breakdown by Type

4.4          Global Market Breakdown by Region

Chapter 5            Global Market Breakdown by Type

5.1          Traditional Human Insulin Market Breakdown by Region

5.2          Modern Human Insulin Market Breakdown by Region

Chapter 6            Global Traditional Human Insulin Market Breakdown by Type

6.1          Short Acting Human Insulin Market Breakdown by Region

6.2          Intermediate Acting Human Insulin Market Breakdown by Region

6.3          Premixed Human Insulin Market Breakdown by Region

Chapter 7            Global Modern Human Insulin Market Breakdown by Type

7.1          Long Acting Human Insulin Market Breakdown by Region

7.2          Rapid Acting Human Insulin Market Breakdown by Region

7.3          Premixed Human Insulin Market Breakdown by Region

Chapter 8            Global Market Breakdown by Brand

Chapter 9            Global Market Breakdown by Region

9.1          North America Market Breakdown by Country, Technology, End Users and Application

   9.1.1      The U.S. market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

   9.1.2      Canada market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

9.2          Europe Market Breakdown by Country, Technology, End Users and Application

   9.2.1      Germany market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

   9.2.2      The U.K. market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

   9.2.3      France market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

9.3          Asia-Pacific Market Breakdown by Country, Technology, End Users and Application

   9.3.1      Japan market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

   9.3.2      China market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

   9.3.3      India market breakdown by type of human insulin, by type of traditional human insulin, and by type of modern human insulin

9.4          Rest of the World (RoW) Market Breakdown by Type, by Type of Traditional human insulin and by Type of Modern Human Insulin

Chapter 10          Competitive Analysis and Market Share

10.1        Porter's Five Forces of Competitive Position Analysis

   10.1.1    Bargaining Power of Buyers

   10.1.2    Bargaining Power of Suppliers

   10.1.3    Threat of New Entrants

   10.1.4    Intensity of Rivalry

   10.1.5    Threat of Substitutes

10.2        Competitive Positioning of Key Competitors

Chapter 11          Company Profiles

11.1        Biocon Ltd.

   11.1.1    Business Overview

   11.1.2    Products and Services

   11.1.3    Recent Developments

   11.1.4    Key P&L Metrics

11.2        TonghuaDongbao Pharmaceuticals Co., Ltd

   11.2.1    Business Overview

   11.2.2    Products and Services

   11.2.3    Recent Developments

   11.2.4    Key P&L Metrics

11.3        ADOCIA               

   11.3.1    Business Overview

   11.3.2    Products and Services

   11.3.3    Recent Developments

   11.3.4    Key P&L Metrics

11.4        Merck & Co.

   11.4.1    Business Overview

   11.4.2    Products and Services

   11.4.3    Recent Developments

   11.4.4    Key P&L Metrics

11.5        Julphar

   11.5.1    Business Overview

   11.5.2    Products and Services

   11.5.3    Recent Developments

   11.5.4    Key P&L Metrics

11.6        Pfizer, Inc.

   11.6.1    Business Overview

   11.6.2    Products and Services

   11.6.3    Recent Developments

   11.6.4    Key P&L Metrics

11.7        Bristol-Myers Squibb Company

   11.7.1    Business Overview

   11.7.2    Products and Services

   11.7.3    Recent Developments

   11.7.4    Key P&L Metrics

11.8        GlaxoSmithKline Plc

   11.8.1    Business Overview

   11.8.2    Products and Services

   11.8.3    Recent Developments

   11.8.4    Key P&L Metrics

11.9        Oramed Pharmaceuticals, Inc.

   11.9.1    Business Overview

   11.9.2    Products and Services

   11.9.3    Recent Developments

   11.9.4    Key P&L Metrics

11.10     Novo Nordisk A/S

   11.10.1  Business Overview

   11.10.2  Products and Services

   11.10.3  Recent Developments

   11.10.4  Key P&L Metrics

11.11     Eli Lilly and Company

   11.11.1  Business Overview

   11.11.2  Products and Services

   11.11.3  Recent Developments

   11.11.4  Key P&L Metrics

11.12     Sanofi  

   11.12.1  Business Overview

   11.12.2  Products and Services

   11.12.3  Recent Developments

   11.12.4  Key P&L Metrics

Chapter 12          Appendix

12.1        List of Abbreviations

TABLE 1                Specific primary and secondary sources used for this publication

TABLE 2                Global human insulin market snapshot (2015 and 2020)

TABLE 3                Drivers for the market: Impact analysis

TABLE 4                Restraints for the market: Impact analysis

TABLE 5                Global human insulin market breakdown by type, $m (2011 – 2014)

TABLE 6                Global human insulin market breakdown by type, $m (2015 – 2020)

TABLE 7                Global traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 8                Global traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 9                Global modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 10              Global modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 11              Global human insulin market breakdown by region, $m (2011 – 2014)

TABLE 12              Global human insulin market breakdown by region, $m (2015 – 2020)

TABLE 13              Global traditional human insulin market breakdown by region, $m (2011 – 2014)

TABLE 14              Global traditional human insulin market breakdown by region, $m (2015 – 2020)

TABLE 15              Global modern human insulin market breakdown by region, $m (2011 – 2014)

TABLE 16              Global modern human insulin market breakdown by region, $m (2015 – 2020)

TABLE 17              Global short acting human insulin market breakdown by region, $m (2011 – 2014)

TABLE 18              Global short acting human insulin market breakdown by region, $m (2015 – 2020)

TABLE 19              Global intermediate acting human insulin market breakdown by region, $m (2011 – 2014)

TABLE 20              Global intermediate acting human insulin market breakdown by region, $m (2015 – 2020)

TABLE 21              Global premixed human insulin market breakdown by region, $m (2011 – 2014)

TABLE 22              Global premixed human insulin market breakdown by region, $m (2015 – 2020)

TABLE 23              Global long acting human insulin market breakdown by region, $m (2011 – 2014)              

TABLE 24              Global long acting human insulin market breakdown by region, $m (2015 – 2020)

TABLE 25              Global rapid acting human insulin market breakdown by region, $m (2011 – 2014)

TABLE 26              Global rapid acting human insulin market breakdown by region, $m (2015 – 2020)

TABLE 27              Global premixed human insulin market breakdown by region, $m (2011 – 2014)

TABLE 28              Global premixed human insulin market breakdown by region, $m (2015 – 2020)

TABLE 29              Some of the human insulin drugs in pipeline by various companies

TABLE 30              Global human insulin market breakdown by brand, $m (2011 – 2014)

TABLE 31              Global human insulin market breakdown by brand, $m (2015 – 2020)

TABLE 32              North America human insulin market breakdown by country, $m (2011 – 2014)

TABLE 33              North America human insulin market breakdown by country, $m (2015 – 2020)

TABLE 34              North America human insulin market breakdown by type, $m (2011 – 2014)

TABLE 35              North America human insulin market breakdown by type, $m (2015 – 2020)

TABLE 36              North America traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 37              North America traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 38              North America modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 39              North America modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 40              The U.S. human insulin market breakdown by type, $m (2011 – 2014)

TABLE 41              The U.S. human insulin market breakdown by type, $m (2015 – 2020)

TABLE 42              The U.S. traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 43              The U.S. traditional human insulin market breakdown by type, $m (2015 – 2020)              

TABLE 44              The U.S. modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 45              The U.S. modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 46              Canada human insulin market breakdown by type, $m (2011 – 2014)

TABLE 47              Canada human insulin market breakdown by type, $m (2015 – 2020)

TABLE 48              Canada traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 49              Canada traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 50              Canada modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 51              Canada modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 52              Europe human insulin market breakdown by country, $m (2011 – 2014)

TABLE 53              Europe human insulin market breakdown by country, $m (2015 – 2020)

TABLE 54              Europe human insulin market breakdown by type, $m (2011 – 2014)

TABLE 55              Europe human insulin market breakdown by type, $m (2015 – 2020)

TABLE 56              Europe traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 57              Europe traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 58              Europe modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 59              Europe modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 60              Germany human insulin market breakdown by type, $m (2011 – 2014)

TABLE 61              Germany human insulin market breakdown by type, $m (2015 – 2020)

TABLE 62              Germany traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 63              Germany traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 64              Germany modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 65              Germany modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 66              The U.K. human insulin market breakdown by type, $m (2011 – 2014)

TABLE 67              The U.K. human insulin market breakdown by type, $m (2015 – 2020)

TABLE 68              The U.K. traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 69              The U.K. traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 70              The U.K. modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 71              The U.K. modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 72              France human insulin market breakdown by type, $m (2011 – 2014)

TABLE 73              France human insulin market breakdown by type, $m (2015 – 2020)

TABLE 74              France traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 75              France traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 76              France modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 77              France modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 78              Asia-Pacific human insulin market breakdown by country, $m (2011 – 2014)

TABLE 79              Asia-Pacific human insulin market breakdown by country, $m (2015 – 2020)

TABLE 80              Asia-Pacific human insulin market breakdown by type, $m (2011 – 2014)              

TABLE 81              Asia-Pacific human insulin market breakdown by type, $m (2015 – 2020)

TABLE 82              Asia-Pacific traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 83              Asia-Pacific traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 84              Asia-Pacific modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 85              Asia-Pacific modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 86              Japan human insulin market breakdown by type, $m (2011 – 2014)

TABLE 87              Japan human insulin market breakdown by type, $m (2015 – 2020)

TABLE 88              Japan traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 89              Japan traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 90              Japan modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 91              Japan modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 92              China human insulin market breakdown by type, $m (2011 – 2014)

TABLE 93              China human insulin market breakdown by type, $m (2015 – 2020)

TABLE 94              China traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 95              China traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 96              China modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 97              China modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 98              India human insulin market breakdown by type, $m (2011 – 2014)

TABLE 99              India human insulin market breakdown by type, $m (2015 – 2020)

TABLE 100            India traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 101            India traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 102            India modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 103            India modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 104            Rest of the World human insulin market breakdown by type, $m (2011 – 2014)

TABLE 105            Rest of the World human insulin market breakdown by type, $m (2015 – 2020) 

TABLE 106            Rest of the World traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 107            Rest of the World traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 108            Rest of the World modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 109            Rest of the World modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 110            Biocon Ltd.– Key Facts

TABLE 111            TonghuaDongbao Pharmaceuticals Co., Ltd. – Key Facts

TABLE 112            ADOCIA – Key Facts

TABLE 113            Merck & Co. – Key Facts

TABLE 114            Julphar – Key Facts

TABLE 115            Pfizer, Inc.– Key Facts

TABLE 116            Bristol-Myers Squibb Company – Key Facts

TABLE 117            GlaxoSmithKline Plc – Key Facts

TABLE 118            Oramed Pharmaceuticals, Inc. – Key Facts

TABLE 119            Novo Nordisk A/S – Key Facts

TABLE 120            Eli Lilly and Company – Key Facts

TABLE 121            Sanofi – Key Facts           

FIG. 1    Market scope for global human insulin market

FIG. 2    Research methodology for global human insulin market

FIG. 3    Production of human insulin

FIG. 4    Aging population in major regions, in % (2000 – 2050)

FIG. 5    Number of people suffering from diabetes aged 20-79 years, 2013 and 2035

FIG. 6    Prevalence of overweight men aged 30 and above, in % (2005 and 2015)

FIG. 7    Prevalence of overweight women aged 30 and above, in % (2005 and 2015)

FIG. 8    Global human insulin market share by type (2014)

FIG. 9    Global traditional human insulin market share by type (2014)

FIG. 10    Global modern human insulin market share by type (2014)

FIG. 11    Global human insulin market share by region (2014)

FIG. 12  Global traditional human insulin market share by region (2014)

FIG. 13  Global modern human insulin market share by region (2014)

FIG. 14  Global short acting human insulin market share by region (2014)              

FIG. 15  Global intermediate acting human insulin market share by region (2014)

FIG. 16  Global premixed human insulin market share by region (2014)

FIG. 17  Global long acting human insulin market share by region (2014)

FIG. 18  Global rapid acting human insulin market share by region (2014)

FIG. 19  Global premixed human insulin market share by region (2014)

FIG. 20  Global human insulin market share by brand (2014)

FIG. 21  North American human insulin market share by country (2014)

FIG. 22  North America human insulin market share by type (2014)

FIG. 23  North America traditional human insulin market share by type (2014)

FIG. 24  North America modern human insulin market share by type (2014)

FIG. 25  The U.S. human insulin market share by type (2014)

FIG. 26  The U.S. traditional human insulin market share by type (2014)

FIG. 27  The U.S. modern human insulin market share by type (2014)

FIG. 28  Canada human insulin market share by type (2014)

FIG. 29  Canada traditional human insulin market share by type (2014)

FIG. 30  Canada modern human insulin market share by type (2014)

FIG. 31  Europe human insulin market share by country (2014)

FIG. 32  Europe human insulin market share by type (2014)

FIG. 33  Europe traditional human insulin market share by type (2014)

FIG. 34  Europe modern human insulin market share by type (2014)

FIG. 35  Germany human insulin market share by type (2014)

FIG. 36  Germany traditional human insulin market share by type (2014)

FIG. 37  Germany modern human insulin market share by type (2014)

FIG. 38  The U.K. human insulin market share by type (2014)

FIG. 39  The U.K. traditional human insulin market share by type (2014)

FIG. 40  The U.K. modern human insulin market share by type (2014)

FIG. 41  France human insulin market share by type (2014

FIG. 42  France traditional human insulin market share by type (2014)

FIG. 43  France modern human insulin market share by type (2014)

FIG. 44  Asia-Pacific human insulin market share by country (2014)

FIG. 45  Asia-Pacific human insulin market share by type (2014)

FIG. 46  Asia-Pacific traditional human insulin market share by type (2014)

FIG. 47  Asia-Pacific modern human insulin market share by type (2014)

FIG. 48  Japan human insulin market share by type (2014)

FIG. 49  Japan traditional human insulin market share by type (2014)

FIG. 50  Japan modern human insulin market share by type (2014)

FIG. 51  China human insulin market share by type (2014)

FIG. 52  China traditional human insulin market share by type (2014)

FIG. 53  China modern human insulin market share by type (2014)

FIG. 54  India human insulin market share by type (2014)

FIG. 55  India traditional human insulin market share by type (2014)

FIG. 56  India modern human insulin market share by type (2014)

FIG. 57  Rest of the World human insulin market share by type (2014)

FIG. 58  Rest of the World traditional human insulin market share by type (2014)

FIG. 59  Rest of the World modern human insulin market share by type (2014)

FIG. 60  Porter’s five forces of competitive position analysis

FIG. 61  Competitive positioning of key competitors

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +